Diffusion Pharmaceuticals Inc. (38)

Browse by Contract Category

Contracts

Form of Underwriter Warrant (Filed With SEC on February 18, 2021)
Employment Agreement, dated as of October 19, 2020, by and between Diffusion Pharmaceuticals Inc. and Christopher D. Galloway (Filed With SEC on October 20, 2020)
Engagement Letter, dated March 27, 2020, by and between the Company and H.C. Wainwright & Co. LLC (Filed With SEC on May 20, 2020)
Amended & Restated Underwriting Agreement, dated February 11, 2021, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 18, 2021)
Employment Agreement, dated as of September 23, 2020, by and between Diffusion Pharmaceuticals Inc. and William R. Elder (Filed With SEC on September 25, 2020)
Employment Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and Robert J. Cobuzzi, Ph.D (Filed With SEC on September 9, 2020)
Separation Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and David G. Kalergis (Filed With SEC on September 9, 2020)
Form of Warrant (Filed With SEC on May 20, 2020)
Form of Securities Purchase Agreement, dated May 18, 2020, by and among the Company and the purchasers party thereto (Filed With SEC on May 20, 2020)
Form of New Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)
Form of Placement Agent Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)
Warrant Exercise Agreement, dated May 6, 2020, by and between Diffusion Pharmaceuticals Inc. and the purchaser thereto (Filed With SEC on May 8, 2020)
Consulting Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)
Separation Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)
Description of Securities (Filed With SEC on March 17, 2020)
Form of Securities Purchase Agreement, dated December 11, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on December 13, 2019)
Form of Placement Agent Warrant (Filed With SEC on December 13, 2019)
Form of Warrant (Filed With SEC on December 13, 2019)
Engagement Letter, dated December 11, 2019, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on December 13, 2019)
Securities Purchase Agreement (Filed With SEC on November 13, 2019)
Form of Wainwright Warrant (Filed With SEC on November 13, 2019)
Form of Pre-Funded Warrant (Filed With SEC on November 13, 2019)
Form of Series II Warrant (Filed With SEC on November 13, 2019)
Form of Series I Warrant (Filed With SEC on November 13, 2019)
Form of Underwriters Warrant (Filed With SEC on November 8, 2019)
Form of Securities Purchase Agreement (Filed With SEC on November 8, 2019)
Engagement Letter, dated October 7, 2019, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 8, 2019)
Form of Placement Agents Warrant (Filed With SEC on November 8, 2019)
Form of Pre-Funded Warrant (Filed With SEC on November 8, 2019)
Form of Common Warrant (Filed With SEC on November 8, 2019)
Form of Underwriters Warrant (Filed With SEC on October 28, 2019)
Form of Pre-Funded Warrant (Filed With SEC on October 28, 2019)
Form of Common Warrant (Filed With SEC on October 28, 2019)
Form of Underwriting Agreement, dated [_______], by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on October 28, 2019)
Form of Placement Agent Warrant (Filed With SEC on May 28, 2019)
Engagement Letter, dated May 3, 2019, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 28, 2019)
Form of Securities Purchase Agreement, dated May 23, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on May 28, 2019)
Form of Warrant (Filed With SEC on May 28, 2019)